Immediate Impact
1 from Science/Nature 50 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
Targeting ROS in cancer: rationale and strategies
2024 Standout
Works of Su‐Peng Yeh being referenced
Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Su‐Peng Yeh | 487 | 171 | 170 | 394 | 61 | 900 | |
| Jean‐Baptiste Micol | 704 | 297 | 133 | 439 | 59 | 1.0k | |
| Sarah Bertoli | 762 | 234 | 209 | 438 | 64 | 1.0k | |
| Danian Nie | 345 | 120 | 144 | 286 | 57 | 741 | |
| Suzanne Tavitian | 455 | 167 | 124 | 195 | 58 | 831 | |
| Claire Oudin | 550 | 209 | 193 | 271 | 39 | 1.1k | |
| Hiroshi Tsutani | 426 | 127 | 156 | 321 | 77 | 948 | |
| Stephen Caplan | 315 | 147 | 159 | 366 | 34 | 880 | |
| Peter Ernst | 344 | 113 | 199 | 288 | 40 | 807 | |
| Wanzhuo Xie | 456 | 99 | 209 | 457 | 77 | 1.1k | |
| Dong Soon Lee | 564 | 250 | 200 | 321 | 75 | 866 |
All Works
Login with ORCID to disown or claim papers
Loading papers...